Table 6 Gram-negative bacteria sensitivity
Cephalosporin | Tazocin | Amikacin | Gentamycin | Cefipiem | Carbapenems | Levofloxacin | |
|---|---|---|---|---|---|---|---|
E. Coli (ESBL −ve) (n = 8) | 100% | 87 % | 87% | 50 % | 100% | 100% | 37.5 % |
K. pneumonia (ESBL −ve) (n = 23) | 100% | 52% | 87% | 74% | 82 % | 100% | 56% |
Acinetobacter baumanii (n = 13) | 30% | 50% | 50% | 50 % | 50% | 50 % | 15% |
Enterobacter cloacae (n = 10) | 50 % | 50% | 70% | 60% | 80% | 100% | 70% |
MDR Acinetobacter baumannii (n = 2) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Acinetobacter junii (n = 1) | 100% | 100% | 100% | 100% | 100% | 100% | NA |
Acinetobacter lowffii (n = 3) | 100% | 100% | 100% | 100% | 100% | 100% | Na |
Aeromonas salmonicidia (n = 1) | 100% | 100% | 100% | 100% | 100% | 100% | 100% |
Cornobacter sakazaki (n = 1) | 100% | 100% | 100% | 100% | 100% | 100% | 0 |
K. pneumonia (ESBL +ve) (n = 4) | 0 | 50% | 75% | 25% | 0% | 100% | 100% |
Pantoea agglomerans (n = 4) | 100% | 100% | 100% | 100% | 100% | 100% | 100% |
Proteus mirabilis (n = 1) | 0 | 100% | 100% | 100% | 0 | 100% | NA |
E. Coli (ESBL +ve) (n = 16) | 0 | 37.5% | 37.5% | 37.5 % | 12.5 % | 100% | 32% |
XDR Pseudomonas aeruginosa (n = 2) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Pseudomonas putida (n = 1) | NA | NA | 100% | NA | 100% | 100% | 0 |
Pseudomonas aeruginosa (n = 6) | 16.60% | 66.6% | 100% | 66.6% | 83.3% | 83.3% | 50% |
Salmonella spp (n = 1) | 100% | NA | NA | NA | 100% | 100% | 100% |
stenotrophomonas maltophilia (n = 4) | 25% | 0 | 25% | 0 | 0 | 0 | 25% |
Sphingomonas paucimobilis (n = 5) | 80% | 100% | 100% | 100% | 100% | 100% | 60% |